- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04565886
Non-surgical Mechanical Therapy of Peri-implantitis With or Without Adjunctive Diode Laser Application
Clinical and Radiographic Outcomes Following Non-surgical Mechanical Therapy of Peri-implantitis With or Without Adjunctive Diode Laser Application: A 12-month Double-blinded Randomized Clinical Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Peri-implantitis is a pathological condition occurring in tissues around dental implants, characterized by inflammation in the peri-implant connective tissue and progressive loss of supporting bone. Peri-implantitis is a disease with increasing incidence that, if left untreated, leads to implant loss. The etiological factors of peri-implant infections are similar to those involved in periodontal diseases. Consequently, the goals of peri-implantitis treatment must be the resolution of peri-implant soft tissue inflammation and stabilization of the bony attachment (e.g., the level of osseointegration). This can only be achieved under the condition that the majority of bacterial biofilms and hard deposits are eliminated on the implant surface to create a biologically acceptable surface conducive to wound healing. Decontamination of the implant surface is mandatory to resolve the inflammatory process and to establish healthy peri-implant tissues. To increase implant surface decontamination, several adjunctive tools have been proposed and investigated both in pre-clinical and clinical studies such as the use of photodynamic therapy and lasers. So far, no data are available to clearly demonstrate the efficacy of the adjunctive use of a diode laser in the non-surgical treatment of peri-implantitis. Therefore, the aim of the present randomized controlled trial (RCT) is to investigate the adjunctive effect of the application of a diode laser to treat peri-implantitis lesions by means of a non-surgical approach. A total of 30 patients is randomly allocated to two groups. The test group receives 3 x nonsurgical mechanical treatment with diode laser application whereas the control group receives the same treatment with sham laser application. The primary outcome is the mean peri-implant pocket probing depth (PPD) at 12 months. The secondary endpoints are:
- Change at deepest PPD (mm)
- Change in probing attachment level (PAL) (mm)
- Change in the % of implants with BoP / SUP
- Mean radiographic bone fill (mm) at mesial and distal sites
- Change in width of keratinized mucosa (KM) (mm)
- Change in microbial samples composition at 6 and 12 months
- Changes in patients' related outcomes measures (PROMs) by means of a Visual Analogue Scale (VAS) (range: 0-10)
- Change in peri-implant crevicular fluid (PICF) composition
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bern, Switzerland, 3010
- Department of Periodontology, University of Bern
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- systemically healthy patients enrolled in regular supportive periodontal therapy (SPT)
- Tissue level (TL) implants with an SLA surface supporting single-unit crowns (SUCs) or fixed dental prostheses (FDPs)
- Pocket Probing Depth (PPD) > 5 mm
- Presence of BoP and /or SU
- Radiographic evidence of crestal bone loss ≤ 2mm based on periapical radiographs after delivery of the final restoration
- Cleansable cemented or screw-retained restoration
- Presence of at least 2 mm of keratinized and attached mucosa (KM)
- Signed informed consent
Exclusion Criteria:
- Systemic diseases that could interfere with the treatment outcome (e.g. uncontrolled diabetes mellitus, chemotherapy, etc.)
- Previous peri-implantitis treatment
- Full-Mouth Plaque Score (FMPS) > 25%
- Full-Mouth Bleeding Score (FMBS) > 25%
- Cigarette smoking > 10 cig./day
- Removable implant-supported restorations
- Implant mobility
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Sham Comparator: control
Non-surgical mechanical instrumentation 3x.
Each time the laser will be held in place but will not be activated.
|
After mechanical debridement, the pockets around the implant will be rinsed with sterile saline solution.
Non-activated (= placebo) adjunctive diode laser will be applied.
The entire treatment procedure, including mechanical debridement, will be performed at Day 0 (= baseline), 7 and 14.
The laser decontamination procedure will occur by systematically moving the laser tip along the subgingival implant surface in a vertical and horizontal scanning way.
|
Experimental: laser
Non-surgical mechanical instrumentation 3x with adjunctive diode laser application according to the protocol of the Department of Periodontology, University of Bern
|
After mechanical debridement, the pockets around the implant will be rinsed with sterile saline solution.
Adjunctive diode laser (settings: 810 nm, 2.5 W, 50 Hz, 10 ms) will be applied 3x for 30 s (i.e., 90 s per appointment) using a 400-lm thick fiber (WhiteStar, Orcos Medical AG, Küsnacht, Switzerland) in the test group.
In the control group, non-activated (= placebo) adjunctive diode laser will be applied.
The entire treatment procedure, including mechanical debridement, will be performed at Day 0 (= baseline), 7 and 14.
The laser decontamination procedure will occur by systematically moving the laser tip along the subgingival implant surface in a vertical and horizontal scanning way.
The laser tip will be checked after 4-5 s for coagulation to prevent hotspots in the soft tissues.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in peri-implant pocket probing depth (PPD)
Time Frame: at 12 months
|
the difference between baseline PPD and PPD after 12 months
|
at 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change at deepest PPD (mm)
Time Frame: at 12 months
|
Difference of baseline and final PPD of the deepest measurment
|
at 12 months
|
Change in probing attachment level (PAL) (mm)
Time Frame: at 12 months
|
Difference of attachment level from baseline to 12 months
|
at 12 months
|
Change in the % of implants with BoP / SUP
Time Frame: at 12 months
|
Difference between baseline and final BoP
|
at 12 months
|
Mean radiographic bone fill (mm) at mesial and distal sites
Time Frame: at 12 months
|
the distance from the implant shoulder to the bone crest
|
at 12 months
|
Change in width of keratinized mucosa (KM) (mm)
Time Frame: at 12 months
|
the difference between the baseline and final amount of KM
|
at 12 months
|
Change in microbial samples composition
Time Frame: at 6 and 12 months
|
at 6 and 12 months
|
|
Changes in patients' related outcomes measures (PROMs) by means of a Visual Analogue Scale (VAS) (range: 0-10)
Time Frame: at 12 months
|
at 12 months
|
|
Change in peri-implant crevicular fluid (PICF) composition
Time Frame: at 12 months
|
at 12 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2019-01163
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peri-Implantitis
-
PolyPid Ltd.MIS Implant Technologies, LtdCompleted
-
University of ManitobaUnknownPeri ImplantitisCanada
-
University of ValenciaCompletedEarly Apical Peri-implantitis
-
Rambam Health Care CampusRecruitingDental Implants,Peri-implantitis,SmokingIsrael
-
Tuğba ŞAHİNCompletedPeri-Implantitis, Peri-implant MucositisTurkey
-
Proed, Torino, ItalyCompleted
-
University of ZagrebNot yet recruitingPeri-implant Mucositis | Peri-Implantitis and Peri-implant Mucositis | Peri-implant Health | Periimplant Diseases | Periimplant Bone Loss
-
National and Kapodistrian University of AthensRecruitingPeri-Implantitis | Peri-Implant HealthGreece
-
Center of Implantology, Oral and Maxillofacial...Recruiting
-
University of BaghdadRecruiting
Clinical Trials on Sham Diode laser
-
University of California, Los AngelesRecruitingSpinal Fusion | Chronic Lower Back PainUnited States
-
Cairo UniversityUnknown
-
Yuzuncu Yıl UniversityCompleted
-
Alexandria UniversityCompletedDentin HypersensitivityEgypt
-
Cynosure, Inc.Completed
-
October 6 UniversityCompleted
-
Dow University of Health SciencesRecruitingOrthodontic Appliance ComplicationPakistan
-
Northwestern UniversityCompleted